Print Page

Letters to Healthcare Providers

 
Valproate: MHRA's reminder of current Pregnancy Prevention Programme requirements; information on new safety measures to be introduced in the coming months (Letter to Healthcare Professionals)
 
 
 
Attachment:
Related Information:
European Union: PRAC assessing new data on potential risk of neurodevelopmental ... Posted 2025-07-12
Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronos... Posted 2025-06-11
The United Kingdom: Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epil... Posted 2025-06-11
Australia: Potential risk of neurodevelopmental disorders in children born to me... Posted 2025-03-07
The United Kingdom: Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epil... Posted 2025-02-14
The United Kingdom: MHRA instructs health organisations to prepare now for new m... Posted 2023-11-30
The United Kingdom: Valproate: reminder of current Pregnancy Prevention Programm... Posted 2022-12-13
台灣:公告修訂含valproate類成分藥品用於婦女的使用原則 (Chinese only) Posted 2019-06-24
Singapore: Epilim® (valproate) – New restrictions on use Posted 2018-10-30
United Kingdom : Valproate Pregnancy Prevention Programme: actions required now ... Posted 2018-09-26
Singapore: Valproate-containing medicines and risk of teratogenicity – An update Posted 2018-09-19
The United Kingdom: Valproate medicines: contraindicated in women and girls of c... Posted 2018-04-25
European Union and the United Kingdom: Information about the risks of taking val... Posted 2018-03-24
Singapore: Epilim® (valproate) - Risk of congenital malformations and serious de... Posted 2018-03-16
PRAC recommends new measures to avoid valproate exposure in pregnancy. New restr... Posted 2018-02-12
European Union: PRAC recommends new measures to avoid valproate exposure in preg... Posted 2018-02-10
The United Kingdom: Valproate and developmental disorders: new alert asking for ... Posted 2017-04-25
European Union: New review of valproate use in pregnancy and women of childbeari... Posted 2017-03-13
European Union: Update on the ongoing review of valproate and related substances Posted 2014-07-14
 
back